| Sep 11 |
Merck’s HPV vaccine meets key goals in Japanese study
|
| Sep 11 |
Merck to Participate in the Bank of America 2024 Global Healthcare Conference
|
| Sep 11 |
Merck Announces Positive Top-line Results from Phase 3 Trial Evaluating Efficacy and Safety of GARDASIL®9 in Japanese Males
|
| Sep 9 |
A Better Drug Than Merck’s Blockbuster Keytruda? Not So Fast
|
| Sep 9 |
Biggest stock movers today: BIG, PLTR, SMMT, and more
|
| Sep 9 |
Merck stock reacts to Summit cancer drug outdoing Keytruda
|
| Sep 9 |
Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
|
| Sep 9 |
Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial
|
| Sep 9 |
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
|
| Sep 7 |
Merck, Daiichi post mid-stage data for novel lung cancer drug
|
